Withdrawal of anticancer therapy in advanced disease: a systematic literature review

BACKGROUND: Current guidelines set out when to start anticancer treatments, but not when to stop as the end of life approaches. Conventional cytotoxic agents are administered intravenously and have major life-threatening toxicities. Newer drugs include molecular targeted agents (MTAs), in particular...

Descripción completa

Detalles Bibliográficos
Autores principales: Clarke, G., Johnston, S., Corrie, P., Kuhn, I., Barclay, S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4641339/
https://www.ncbi.nlm.nih.gov/pubmed/26559912
http://dx.doi.org/10.1186/s12885-015-1862-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4641339/
https://www.ncbi.nlm.nih.gov/pubmed/26559912
http://dx.doi.org/10.1186/s12885-015-1862-0

Ejemplares similares